Dental Manifestations of Pediatric Bone Disorders

Anitha N, et al. Fibrous dysplasia-recent concepts. J Pharm Bioallied Sci. 2015;7(Suppl 1):S171–2.

Weinstein LS, et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med. 1991;325(24):1688–95.

Riminucci M, et al. Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression. Bone. 2003;33(3):434–42.

Riminucci M, et al. The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks. J Pathol. 1999;187(2):249–58.

Hart ES, et al. Onset, progression, and plateau of skeletal lesions in fibrous dysplasia and the relationship to functional outcome. J Bone Miner Res. 2007;22(9):1468–74.

Foster BL, et al. Rare bone diseases and their dental, oral, and craniofacial manifestations. J Dent Res. 2014;93(7 Suppl):7S–19S.

Stanton RP, et al. The surgical management of fibrous dysplasia of bone. Orphanet J Rare Dis. 2012;7(Suppl 1):S1.

Kelly MH, Brillante B, Collins MT. Pain in fibrous dysplasia of bone: age-related changes and the anatomical distribution of skeletal lesions. Osteoporos Int. 2008;19(1):57–63.

Lalam RK, Cassar-Pullicino VN, Winn N. Paget disease of bone. Semin Musculoskelet Radiol. 2016;20(3):287–99.

Cundy HR, et al. Paget’s disease of bone in New Zealand: continued decline in disease severity. Calcif Tissue Int. 2004;75(5):358–64.

Tiegs RD, et al. Long-term trends in the incidence of Paget’s disease of bone. Bone. 2000;27(3):423–7.

Poor G, et al. Epidemiology of Paget’s disease in Europe: the prevalence is decreasing. J Bone Miner Res. 2006;21(10):1545–9.

• Galson DL, Roodman GD. Pathobiology of Paget’s disease of bone. J Bone Metab. 2014;21(2):85–98. This study provides a detail description of the new and more recent knowledge about the physiopathology of Paget’s disease.

Ralston SH, Layfield R. Pathogenesis of Paget disease of bone. Calcif Tissue Int. 2012;91(2):97–113.

Roodman GD. Insights into the pathogenesis of Paget’s disease. Ann N Y Acad Sci. 2010;1192:176–80.

Indumathi CK, Dinakar C, Roshan R. Juvenile Paget’s disease. Indian Pediatr. 2009;46(4):354–6.

Wendlova J, Galbavy S, Paukovic J. Paget’s disease of bone—treatment with alendronate, calcium and calcitriol. Vnitr Lek. 1999;45(10):602–5.

Monti E, et al. Current and emerging treatments for the management of osteogenesis imperfecta. Ther Clin Risk Manag. 2010;6:367–81.

Damm DD. Oral pathology. Oral Surg Oral Med Oral Pathol. 1994;77(1):4–5.

Shaker JL, et al. Recent developments in osteogenesis imperfecta. F1000Res. 2015;4(F1000 Faculty Rev):681.

Hoyer-Kuhn H, et al. A specialized rehabilitation approach improves mobility in children with osteogenesis imperfecta. J Musculoskelet Neuronal Interact. 2014;14(4):445–53.

Majorana A, et al. Dentinogenesis imperfecta in children with osteogenesis imperfecta: a clinical and ultrastructural study. Int J Paediatr Dent. 2010;20(2):112–8.

Kliegman R, Nelson WE. Nelson textbook of pediatrics. 19th ed. Philadelphia: Elsevier/Saunders. lxvii; 2011. p. 2610.

Kalyvas D, et al. Localized jaw enlargement in renal osteodystrophy: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97(1):68–74.

Lopes ML, et al. Severe maxillofacial renal osteodystrophy in two patients with chronic kidney disease. Oral Maxillofac Surg. 2015;19(3):321–7.

Antonelli JR, Hottel TL. Oral manifestations of renal osteodystrophy: case report and review of the literature. Spec Care Dentist. 2003;23(1):28–34.

Orimo H. Pathophysiology of hypophosphatasia and the potential role of asfotase alfa. Ther Clin Risk Manag. 2016;12:777–86.

Anderson HC, et al. Matrix vesicles in osteomalacic hypophosphatasia bone contain apatite-like mineral crystals. Am J Pathol. 1997;151(6):1555–61.

Bloch-Zupan A. Hypophosphatasia: diagnosis and clinical signs—a dental surgeon perspective. Int J Paediatr Dent. 2016;26(6):426–38.

Schlosser BJ, Pirigyi M, Mirowski GW. Oral manifestations of hematologic and nutritional diseases. Otolaryngol Clin N Am. 2011;44(1):183–203. vii

Foster BL, et al. Central role of pyrophosphate in acellular cementum formation. PLoS One. 2012;7(6):e38393.

Mornet E. Hypophosphatasia. Orphanet J Rare Dis. 2007;2:40.

Marrani E, et al. Pediatric osteoporosis: diagnosis and treatment considerations. Drugs. 2017;77(6):679–95.

• Saraff V, Hogler W. Endocrinology and adolescence: osteoporosis in children: diagnosis and management. Eur J Endocrinol. 2015;173(6):R185–97. This article provides to the reader a detailed and completed review in the most updated knowledge of osteoporosis in children.

Russell RG. Bisphosphonates: mode of action and pharmacology. Pediatrics. 2007;119(Suppl 2):S150–62.

Dervis E. Oral implications of osteoporosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100(3):349–56.